TOVX
Theriva Biologics·AMEX
--
--(--)
--
--(--)
3.66 / 10
Netural
Analyst sentiment is weak: only one neutral rating, zero historical win rate and –33.44% average return. Fund‑flow, however, scores 7.32/10 with good inflow ratios (~0.48) but negative trends across all size segments. Capital is entering, yet sentiment remains skeptical.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Jason Wesly MccarthyNeutral
Date2025-05-08
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for TOVX?
- TOVX holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.66/10 (Netural).
